Quote this publication Share Print

VARNOLINE CONTINU

-
Opinions on drugs - Posted on Jun 04 2012

Reason for request

Inclusion on the lists of medicines reimbursed by National Health Insurance and approved for hospital use.

-


Actual benefit

Important

The actual benefit of this proprietary drug is substantial.


Improvement in actual benefit

V (absence)

The Transparency Committee considers that 3rd generation VARNOLINE CONTINU does not provide an improvement in actual benefit (IAB V) compared to 2nd generation oral contraceptives.


Contact Us

Évaluation des médicaments

See also